Keywords: Islet Sciences, DiaKine Therapeutics, Diabetes, M&A

Islet Sciences closes stock acquisition of diabetes drug developer DiaKine

Article | 26 March 2012

Print This

New York. USA-based biotech company Islet Sciences (OTC.BB: ISLT),said Friday that it has closed its previously-announced stock acquisition ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in